Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 of remimazolam with different oxycodone doses for painless gastroscopy in adults
ChiCTR2500105928Phase 4Not yet recruiting
- Sponsor
- Fuyang People's Hospital
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam and oxycodone (2 arms), sponsored by Fuyang People's Hospital. Primary endpoints: Median effective dose (ED50), Remimazolam dosage and 1 more. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
remimazolamoxycodone
Beyond the preview
Go deeper on ChiCTR2500105928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500105928.